(Q56101132)
Statements
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102 (English)
Keith Henry
David Katzenstein
Deborah Weng Cherng
Hernan Valdez
Michelle Blanchard Vargas
Mark Winters
Nasreen C Jahed
Jeffrey M Jacobson
Laurie S Myers
John L Schmitz
A5102 Study Team of the AIDS Clinical Trials Group